Home
Acurx Pharmaceuticals ACXP paid Innovative Federal Strategies $30K for lobbying in Q1 2026 · Budget
Trade details
- Type
- Lobbying report
- Amount
- $30,000
- Quarter
- Q1 2026
- Client
- Acurx Pharmaceuticals
- Reported
- 26/04/20
Up 0.0% from last quarter
What else happened in Acurx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 03/01~04/30Acurx Pharmaceuticals's other lobbying reports
- Acurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
ACXP
$30K
$30K
Reported 07/20
for Q2
- Acurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
ACXP
$30K
$30K
Reported 01/20
for Q4 2025
- Acurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
ACXP
$30K
$30K
Reported 25/10/20
for Q3 2025
- Acurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
ACXP
$30K
$30K
Reported 25/07/18
for Q2 2025
- Acurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
LobbyingAcurx Pharmaceuticals
ACXP
$20K
$20K
Reported 25/04/16
for Q1 2025